Qingdao Haier Biomedical Co.,Ltd.(688139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

688139 Qingdao Haier Biomedical Co.,Ltd.

Closed 08-14 15:00:01

28.84

-0.26

-0.89%

High29.55	Low28.70	Vol2.54M
Open29.11	D1 Closing29.10	Amplitude2.92%
Mkt Cap9.11B	Tradable Cap9.11B	Total Shares316.00M
T/O73.95M	T/O Rate0.81%	Tradable Shares316.00M
P/B2.05	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"688139","market":"SH","secType":"STK","nameCN":"Qingdao Haier Biomedical Co.,Ltd.","latestPrice":28.84,"timestamp":1786690801000,"preClose":29.1,"halted":0,"volume":2544126,"delay":0,"changeRate":-0.0089,"floatShares":316000000,"shares":316000000,"eps":0.695,"marketStatus":"Closed","change":-0.26,"latestTime":"08-14 15:00:01","open":29.11,"high":29.55,"low":28.7,"amount":73953000,"amplitude":0.0292,"askPrice":28.89,"askSize":10,"bidPrice":28.84,"bidSize":21,"shortable":0,"etf":0,"ttmEps":0.695,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"adjPreClose":29.1,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":32.01,"lowLimit":26.19,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":316492922,"isCdr":false,"pbRate":2.05,"roa":"--","peRate":41.496403,"roe":"1.8%","epsLYR":0.8,"committee":0.673774,"marketValue":9128000000,"turnoverRate":0.008,"status":1,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2026-08-17.","afterMarket":{"amount":0,"volume":0,"close":28.84,"buyVolume":0,"sellVolume":0,"time":1786692838801,"indexStatus":"Closed 08-14 15:30:00","preClose":29.1},"floatMarketCap":9128000000},"requestUrl":"/m/hq/s/688139","defaultTab":"news","newsList":[{"id":"2655818503","title":"Minerals Technologies Swings to Q2 Net Loss on Talc-related Litigation Charge","url":"https://stock-news.laohu8.com/highlight/detail?id=2655818503","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655818503?lang=en_us&edition=fundamental","pubTime":"2026-07-31 05:18","pubTimestamp":1785446329,"startTime":"0","endTime":"0","summary":"Minerals Technologies swings to Q2 net loss on talc-related litigation chargeOverviewUS specialty minerals firm's Q2 sales rose 4% yr/yr, missing analyst expectationsAdjusted EPS for Q2 increased 3% y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43W1PN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4011","BK4109","LU2488822045.USD","688139","MTX","USLM","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114858584","title":"Haier Biomedical Announces Share Buyback Plan Valued Between 50 and 100 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1114858584","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114858584?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:49","pubTimestamp":1782982149,"startTime":"0","endTime":"0","summary":"Qingdao Haier Biomedical Co.,Ltd. (688139.SH) has released an announcement regarding a proposed share repurchase initiative.The company intends to utilize its own funds to repurchase shares via a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198669369","title":"Haier Biomedical's Controlling Shareholder Proposes Share Buyback Program Valued Between RMB 50 Million and RMB 100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1198669369","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198669369?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:06","pubTimestamp":1782381989,"startTime":"0","endTime":"0","summary":"The controlling shareholder of Qingdao Haier Biomedical Co.,Ltd. (SH: 688139) has submitted a formal proposal for the company to repurchase its own shares.The proposal, received by the company on...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636897210","title":"Haier Biomedical Publishes 2025 Sustainability Report: Committed to Building a Platform for Technology, Industry and Social Responsibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2636897210","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636897210?lang=en_us&edition=fundamental","pubTime":"2026-05-20 12:23","pubTimestamp":1779250980,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA65NMSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631503922","title":"Press Release: Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2631503922","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631503922?lang=en_us&edition=fundamental","pubTime":"2026-04-30 12:27","pubTimestamp":1777523220,"startTime":"0","endTime":"0","summary":"AI-powered growth surges as Haier Biomedical scales from product coverage to premium brand leadership, building a global life science tools and intelligent productivity platform. QINGDAO, China, April 30, 2026 /CNW/ -- Haier Biomedical , a global leader in life sciences and medical solutions, has officially published its 2025 annual report, posting full--year revenue of 2.33 billion yuan  with overseas revenue growing 17.9% year-on-year to 840 million yuan , accounting for 36% of total revenue -- a record high. Despite a complex global trade environment, Haier Biomedical delivered double--digit growth across all international business sectors.Haier Biomedical continued to optimize its revenue structure in 2025, with new market sectors and overseas operations emerging as core engines of growth. New business segments such as smart medication, blood technology, laboratory solutions and more contributed 48.5% of total revenue, representing an 8.8% year-on-year increase.Its ultra--low and l","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","BK0251","BK4528","LU2488822045.USD","CHAT","ARTY","BK4551","BK4588","BK4023","AGIX","BK4585","AIYY","AIPO","BK4587","688139","AI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142961478","title":"Haier Biomedical Debuts AI-Powered Autonomous Lab at CMEF, Building an \"AI Foundation\" for Life Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=1142961478","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142961478?lang=en_us&edition=fundamental","pubTime":"2026-04-16 14:33","pubTimestamp":1776321220,"startTime":"0","endTime":"0","summary":"At the 93rd China International Medical Equipment Fair (CMEF), nearly 5,000 enterprises from over 30 countries and regions competed on the same stage. During the event, Qingdao Haier Biomedical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","ARTY","688139","BK0251","LU2488822045.USD","AGIX","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173194810","title":"Biomedical Storage Leader Reports Fourth Consecutive Annual Profit Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1173194810","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173194810?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:20","pubTimestamp":1774959657,"startTime":"0","endTime":"0","summary":"Qingdao Haier Biomedical Co., Ltd. has reported its 2025 annual results, revealing a continued pattern of revenue growth without corresponding profit increases. The company announced revenue of 2.329...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133468420","title":"Haier Biomedical Highlights Industry Traits of Vast Market, Niche Segments, Diverse Products and Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=1133468420","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133468420?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:12","pubTimestamp":1772543526,"startTime":"0","endTime":"0","summary":"Qingdao Haier Biomedical Co., Ltd. stated during an investor inquiry that the industry it operates in is characterized by a large total market size, numerous niche segments, a wide array of products,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107989005","title":"Haier Biomedical Reports 31.6% Decline in 2025 Net Profit Attributable to Owners","url":"https://stock-news.laohu8.com/highlight/detail?id=1107989005","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107989005?lang=en_us&edition=fundamental","pubTime":"2026-02-27 16:10","pubTimestamp":1772179822,"startTime":"0","endTime":"0","summary":"Qingdao Haier Biomedical Co.,Ltd. (688139.SH) has released its preliminary financial results for the year 2025. The company achieved operating revenue of 2.33 billion yuan, representing a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786879631403,"stockEarnings":[{"period":"1week","weight":-0.0103},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.1404},{"period":"6month","weight":-0.1054},{"period":"1year","weight":-0.1477},{"period":"ytd","weight":-0.0814}],"compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0072},{"period":"3month","weight":-0.0503},{"period":"6month","weight":-0.0379},{"period":"1year","weight":0.0711},{"period":"ytd","weight":-0.0105}],"compareStock":{"symbol":"000001.SH","name":"SSE Comp"},"companyName":"青岛海尔生物医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"14595人(较上一季度增加2.01%)","perCapita":"21685股","listingDate":"2019-10-25","address":"山东省青岛市城阳区高新区丰源路280号","registeredCapital":"31649万元","survey":"　　青岛海尔生物医疗股份有限公司的主营业务是为高校科研、医药生物企业、医院、疾控、血站、基层公卫等用户提供数字化场景解决方案。公司的主要产品是智慧实验室制药工艺、数字医院、智慧公共卫生、智慧用血。报告期内，公司低温存储技术持续领先，依托制冷平台，通过持续优化制冷系统设计、温湿控制和节能技术等核心模块，在极致稳定、绿色效能方向上构筑起代际领先优势。","listedPrice":15.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Qingdao Haier Biomedical Co.,Ltd.(688139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Qingdao Haier Biomedical Co.,Ltd.(688139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Qingdao Haier Biomedical Co.,Ltd.,688139,Qingdao Haier Biomedical Co.,Ltd.股票,Qingdao Haier Biomedical Co.,Ltd.股票老虎,Qingdao Haier Biomedical Co.,Ltd.股票老虎国际,Qingdao Haier Biomedical Co.,Ltd.行情,Qingdao Haier Biomedical Co.,Ltd.股票行情,Qingdao Haier Biomedical Co.,Ltd.股价,Qingdao Haier Biomedical Co.,Ltd.股市,Qingdao Haier Biomedical Co.,Ltd.股票价格,Qingdao Haier Biomedical Co.,Ltd.股票交易,Qingdao Haier Biomedical Co.,Ltd.股票购买,Qingdao Haier Biomedical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Qingdao Haier Biomedical Co.,Ltd.(688139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Qingdao Haier Biomedical Co.,Ltd.(688139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction